Reliance Global Group (EZRA) Registration filing summary
Event summary combining transcript, slides, and related documents.
Registration filing summary
27 Aug, 2026Company overview and business model
Operates as a diversified company focused on insurance, technology, and healthcare sectors, with a primary strategy of acquiring and optimizing wholesale and retail insurance agencies.
Developed proprietary InsurTech platforms, including 5MinuteInsure.com for consumers and RELI Exchange for agency partners, leveraging AI and data mining.
Pursues growth through acquisitions, technology investments, and expansion into healthcare via EZRA International Group and LifeSci Global Group.
Financial performance and metrics
As of the prospectus date, approximately $1.6 million of common stock had been sold under the White Lion Purchase Agreement, with $48.4 million of the $50 million commitment remaining.
Completed a $2.0 million public offering in January 2026 and utilized an at-the-market program for additional capital during 2026.
Use of proceeds and capital allocation
Proceeds from sales under the White Lion Purchase Agreement will be used for working capital, operations, debt payments, capital investments, and general corporate purposes.
Management retains broad discretion over allocation of proceeds, with potential investment in interest-bearing securities pending use.
Latest events from Reliance Global Group
- Operating expenses down 28%, net loss improved 26%, and AI platform to generate revenue soon.EZRA
Q2 2026 - Net loss improved, cash and equity grew, and insurance saw 11% organic growth.EZRA
Q1 2026 - All proposals passed, with leadership focused on growth and stockholder value.EZRA
AGM 2026 - Strategic investment in Innervate Radiopharmaceuticals advances late-stage healthcare platform exposure.EZRA
Proxy filing - Annual meeting seeks approval for director elections, equity plan expansion, and major share issuance.EZRA
Proxy filing - Shareholders will vote on director elections, equity plan expansion, and a $50M share issuance.EZRA
Proxy Filing - Strategic tech expansion, divestitures, and improved financials position for future growth.EZRA
Q4 2025 - Raising $5.3M for growth, tech, and digital assets amid dilution and Nasdaq compliance risks.EZRA
Registration Filing - Q2 net loss improved 62%, Spetner deal to double revenue and boost profitability.EZRA
Q2 2024